# Ocular Sarcoidosis Open Label Trial of ACTHAR Gel

> **NCT02725177** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 9 (actual)

## Conditions studied

- Ocular Sarcoidosis
- Panuveitis
- Anterior Uveitis

## Interventions

- **DRUG:** Repository Corticotropin Injection
- **DRUG:** Repository Corticotropin Injection -Treatment Extension

## Key facts

- **NCT ID:** NCT02725177
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2021-12
- **Final completion:** 2022-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02725177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02725177, "Ocular Sarcoidosis Open Label Trial of ACTHAR Gel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02725177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*